Follow
Joe-elie Salem
Joe-elie Salem
Verified email at aphp.fr - Homepage
Title
Cited by
Cited by
Year
Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis
DY Wang, JE Salem, JV Cohen, S Chandra, C Menzer, F Ye, S Zhao, ...
JAMA oncology 4 (12), 1721-1728, 2018
20272018
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology …
AR Lyon, T López-Fernández, LS Couch, R Asteggiano, MC Aznar, ...
European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022
12962022
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
JE Salem, A Manouchehri, M Moey, B Lebrun-Vignes, L Bastarache, ...
The Lancet Oncology 19 (12), 1579-1589, 2018
9002018
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
JJ Moslehi, JE Salem, JA Sosman, B Lebrun-Vignes, DB Johnson
The Lancet 391 (10124), 933, 2018
7692018
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised …
G Cayla, T Cuisset, J Silvain, F Leclercq, S Manzo-Silberman, ...
The Lancet 388 (10055), 2015-2022, 2016
399*2016
Abatacept for severe immune checkpoint inhibitor–associated myocarditis
JE Salem, Y Allenbach, A Vozy, N Brechot, DB Johnson, JJ Moslehi, ...
New England Journal of Medicine 380 (24), 2377-2379, 2019
3512019
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ...
Annals of the rheumatic diseases 78 (2), 209-217, 2019
3462019
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
S Vieira-Silva, G Falony, E Belda, T Nielsen, J Aron-Wisnewsky, ...
Nature 581 (7808), 310-315, 2020
3442020
Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology
MP Bonaca, BA Olenchock, JE Salem, SD Wiviott, S Ederhy, A Cohen, ...
Circulation 140 (1), 80-91, 2019
3342019
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
DB Johnson, A Manouchehri, AM Haugh, HT Quach, JM Balko, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
2792019
Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines
J Alexandre, J Cautela, S Ederhy, GL Damaj, JE Salem, F Barlesi, ...
Journal of the American Heart Association 9 (18), e018403, 2020
2242020
Cardiovascular toxicities associated with ibrutinib
JE Salem, A Manouchehri, M Bretagne, B Lebrun-Vignes, JD Groarke, ...
Journal of the American College of Cardiology 74 (13), 1667-1678, 2019
2152019
A genetic mouse model recapitulates immune checkpoint inhibitor–associated myocarditis and supports a mechanism-based therapeutic intervention
SC Wei, WC Meijers, ML Axelrod, NAAS Anang, EM Screever, ...
Cancer discovery 11 (3), 614-625, 2021
1772021
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin
I Gouin‐Thibault, X Delavenne, A Blanchard, V Siguret, JE Salem, ...
Journal of Thrombosis and Haemostasis 15 (2), 273-283, 2017
1752017
Immune checkpoint inhibitor–associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution
C Anquetil, JE Salem, B Lebrun-Vignes, DB Johnson, AL Mammen, ...
Circulation 138 (7), 743-745, 2018
1732018
Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes
L Genser, D Aguanno, HA Soula, L Dong, L Trystram, K Assmann, ...
The Journal of pathology 246 (2), 217-230, 2018
1722018
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
A Molinaro, P Bel Lassen, M Henricsson, H Wu, S Adriouch, E Belda, ...
Nature Communications 11 (1), 5881, 2020
1662020
Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal Src kinase
L Xiao, JE Salem, S Clauss, A Hanley, A Bapat, M Hulsmans, Y Iwamoto, ...
Circulation 142 (25), 2443-2455, 2020
1582020
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
DB Johnson, WJ McDonnell, PI Gonzalez-Ericsson, RN Al-Rohil, ...
Nature medicine 25 (8), 1243-1250, 2019
1562019
Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation
LS Nguyen, M Vautier, Y Allenbach, N Zahr, O Benveniste, ...
Drug safety 42, 813-825, 2019
1492019
The system can't perform the operation now. Try again later.
Articles 1–20